What is the recommended titration schedule for Vyvanse (lisdexamfetamine) in the treatment of Attention Deficit Hyperactivity Disorder (ADHD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Vyvanse Titration Schedule for ADHD

Starting Dose and Titration Protocol

Begin Vyvanse at 30 mg once daily in the morning, then increase by 10-20 mg at weekly intervals until optimal symptom control is achieved, with a typical maintenance dose of 50-70 mg daily and a maximum of 70 mg/day. 1, 2, 3

Specific Titration Algorithm

Standard Weekly Titration

  • Week 1: Start 30 mg every morning 2, 3
  • Week 2 onward: Increase by 10 mg increments at approximately weekly intervals 1
  • Alternative approach: Some clinicians use 20 mg weekly increments for faster titration 1, 2
  • Target range: 30-70 mg daily, with most patients requiring 50-70 mg for optimal maintenance 2
  • Maximum dose: 70 mg per day 2, 3

Special Population Adjustments

  • Children <20 kg (45 lb): Omit the 15 mg dose and corresponding week in the titration schedule 4
  • Severe renal impairment: Maximum dose is 50 mg/day 3
  • End-stage renal disease: Maximum dose is 30 mg/day 3

Monitoring Requirements During Titration

Weekly Assessment Protocol

  • Contact frequency: Maintain weekly telephone contact during initial titration and dose adjustments 2
  • Rating scales: Obtain standardized ADHD rating scales (such as ADHD-RS-IV) from both parents and teachers before each dose increase 1, 4
  • Vital signs: Assess blood pressure, pulse, height, and weight at each visit 1, 4
  • Time to optimal dosing: Typically requires 2-4 weeks to reach optimal dosing 2

Systematic Side Effect Assessment

Ask specific questions about known stimulant side effects at each contact 2:

  • Insomnia
  • Decreased appetite and weight loss
  • Headaches
  • Increased blood pressure and pulse
  • Anxiety or irritability

Alternative Titration Strategy

Forced titration approach: Some clinicians use a structured protocol where the child receives all dose levels (30 mg, 50 mg, 70 mg) for one week each, with rating scales collected at each dose to identify the optimal level 1. This approach allows for systematic comparison of responses across doses.

Administration Timing

  • Administer in early morning to provide coverage throughout the school day and minimize sleep disturbances 1
  • Duration of action: Lisdexamfetamine provides symptom control for 13 hours in children and 14 hours in adults 5, 6

Post-Stabilization Monitoring

  • Follow-up frequency: Schedule appointments at least monthly after stabilization 2
  • Ongoing assessment: Continue monitoring efficacy, side effects, and growth parameters (height, weight, blood pressure, pulse) 2
  • Dose adjustments: Remain vigilant for need to adjust doses due to changes in symptomatology, psychosocial situation, or normal development 2

Critical Pitfalls to Avoid

  • Starting too high: Beginning at doses above 30 mg can lead to unnecessary side effects and decreased medication adherence 2
  • Inadequate monitoring: Failure to systematically assess both benefits and side effects during titration compromises treatment optimization 2
  • Insufficient trial duration: Each dose level should be maintained for approximately one week to adequately assess response 1, 2

When Maximum Dose Is Inadequate

If adequate symptom control is not achieved at 70 mg daily: Consider alternative treatments or adding non-stimulant medications 2. Lisdexamfetamine should be the preferred next stimulant option if no desired benefit is observed after adequate treatment with methylphenidate 2.

Pre-Treatment Assessment

  • Cardiac screening: Assess for presence of cardiac disease before initiating treatment 3
  • Abuse risk: Assess each patient's risk for abuse, misuse, and addiction before prescribing 3
  • Psychiatric screening: Screen for risk factors for developing manic episodes or psychotic symptoms 3

References

Guideline

Lisdexamfetamine Dosing and Monitoring for ADHD

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Dosing and Monitoring of Vyvanse for ADHD

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Lisdexamfetamine Dosing and Administration for ADHD and Binge Eating Disorder

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.